Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany

PURPOSE: Systemic therapy choice for patients with recurrent and/or metastatic head and neck cancer (R/M HNC) is a challenge. Not much is known about systemic therapies used in daily clinical routine and their outcome. METHODS: Data of all 283 patients with R/M HNC (89.4% male, median age: 60 years)...

Descripción completa

Detalles Bibliográficos
Autores principales: Morkramer, Lisa, Geitner, Maren, Boeger, Daniel, Buentzel, Jens, Kaftan, Holger, Mueller, Andreas H., Ernst, Thomas, Guntinas-Lichius, Orlando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310840/
https://www.ncbi.nlm.nih.gov/pubmed/33517469
http://dx.doi.org/10.1007/s00432-021-03535-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310840/
https://www.ncbi.nlm.nih.gov/pubmed/33517469
http://dx.doi.org/10.1007/s00432-021-03535-4

Ejemplares similares